Combined TMS-EEG For Early Diagnosis Of Alzheimer’s Disease
Funder
National Health and Medical Research Council
Funding Amount
$603,767.00
Summary
Early diagnosis of Alzheimer's disease is key to more effective early intervention. Current biomarkers are expensive and are not suited for detecting the subtle changes in brain function that occur during the initial stages of the disease. Non-invasive brain stimulation is pain-free and inexpensive, and can directly probe brain function in conscious humans. This project will investigate whether these techniques might be used to identify markers of early brain dysfunction in Alzheimer’s disease.